We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Groundbreaking AI-Based Method Accurately Classifies Cardiac Function and Disease Using Chest X-Rays

By HospiMedica International staff writers
Posted on 07 Jul 2023

Valvular heart disease, a leading cause of heart failure, is commonly diagnosed using echocardiography. More...

However, this technique demands specialized expertise, leading to a shortage of proficient technicians. Chest radiography, on the other hand, is a widely used diagnostic method for identifying primarily lung diseases. Even though the heart is visible in chest radiographs or chest X-rays, its potential to detect cardiac function or disease has been largely unexplored until now. Given their widespread use, rapid execution, and high reproducibility, chest X-rays could serve as a supplementary tool to echocardiography for diagnosing cardiac conditions if they could accurately determine cardiac function and disease. Now, an innovative artificial intelligence (AI) tool uses chest X-rays to classify cardiac functions and identify valvular heart disease with unprecedented accuracy.

Scientists at Osaka Metropolitan University (Osaka, Japan) have developed an AI-based model capable of accurately classifying cardiac functions and diagnosing valvular heart diseases using chest X-rays. Given the potential for bias and resultant low accuracy if AI is trained on a single dataset, the team collected a multi-institutional dataset comprising 22,551 chest X-rays and corresponding echocardiograms from 16,946 patients across four facilities between 2013 and 2021. The AI model was trained using chest X-rays as input data and the corresponding echocardiograms as output data, enabling it to learn the features connecting the two datasets.

The AI model succeeded in precisely classifying six selected types of valvular heart disease, with the Area Under the Curve (AUC is a rating index denoting an AI model's capability with a value range from 0 to 1—the closer to 1, the better) ranging from 0.83 to 0.92. The AUC was 0.92 at a 40% cut-off for detecting left ventricular ejection fraction—an essential metric for monitoring cardiac function.

“It took us a very long time to get to these results, but I believe this is significant research,” stated Dr. Daiju Ueda from Osaka Metropolitan University who led the research team. “In addition to improving the efficiency of doctors’ diagnoses, the system might also be used in areas where there are no specialists, in night-time emergencies, and for patients who have difficulty undergoing echocardiography.”

Related Links:
Osaka Metropolitan University 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.